Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer

Most differentiated thyroid cancer (DTC) patients have an excellent prognosis. However, about one-third of DTC patients with recurrent or metastatic disease lose the hallmark of specific iodine uptake initially or gradually and acquire radioactive iodine-refractory DTC (RAIR-DTC) with poor prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Zhuan-Zhuan, Zhang, Xin, Lin, Yan-Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769251/
https://www.ncbi.nlm.nih.gov/pubmed/31598469
http://dx.doi.org/10.4068/cmj.2019.55.3.127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769251/
https://www.ncbi.nlm.nih.gov/pubmed/31598469
http://dx.doi.org/10.4068/cmj.2019.55.3.127

Ejemplares similares